Ketamine has a complicated public image. Most people know it as a club drug, a veterinary sedative, or something vaguely illicit. What gets far less attention is its decades-long track record as one of the safest anesthetic agents in clinical medicine, alongside a growing body of research supporting its use in mental health treatment.

So: is ketamine safe for depression, PTSD, and anxiety? The honest answer is yes, under proper clinical conditions, but that answer comes with important context worth understanding.

Ketamine’s Medical History

Ketamine was developed in the 1960s and approved by the FDA in 1970 as a general anesthetic. It’s been on the World Health Organization’s List of Essential Medicines since 1985. In emergency medicine, field surgery, and pediatric anesthesia, ketamine is prized precisely because of its safety profile: unlike most anesthetics, it doesn’t suppress breathing, making it safer to use in resource-limited settings without mechanical ventilation.

This isn’t fringe medicine. Ketamine is one of the most studied drugs in anesthesiology, with decades of data on its effects, side effects, and contraindications.

Therapeutic Doses Are Much Lower Than Anesthetic Doses

This is the critical distinction that often gets lost. Recreational ketamine abuse involves high, repeated doses. Anesthetic use involves doses high enough to induce unconsciousness. Therapeutic ketamine for mental health conditions uses sub-anesthetic doses, typically 0.5 mg/kg administered intravenously over 40–60 minutes, that produce a dissociative, dream-like state without loss of consciousness.

At these doses, the risk profile is substantially different from either recreational or anesthetic use.

What the Research Shows

The clinical evidence for therapeutic IV ketamine has grown substantially over the past two decades. Key findings include:

  • A landmark 2000 study published in Biological Psychiatry (Berman et al.) demonstrated rapid antidepressant effects from a single sub-anesthetic ketamine infusion in patients with depression, with results that appeared within hours. A 2006 randomized trial in Archives of General Psychiatry (Zarate et al.) replicated and extended these findings in treatment-resistant patients.
  • Meta-analyses of randomized controlled trials consistently show significant antidepressant response rates in TRD patients, with effects emerging faster than any conventional medication.
  • The FDA’s 2019 approval of esketamine (Spravato®), a ketamine-derived nasal spray, for treatment-resistant depression validated the mechanism, even if IV ketamine and esketamine differ in meaningful ways. Use of ketamine in mood disorders is also supported by an American Psychiatric Association consensus statement (Sanacora et al., 2017).
  • Research on PTSD, OCD, and anxiety disorders has shown similarly promising early results, though these indications have smaller evidence bases than depression.

Common Side Effects During Infusion

Most side effects associated with therapeutic ketamine are transient: they occur during the infusion and resolve as the drug clears the system. They include:

  • Dissociation: The most expected effect, involving altered perception of time, space, and self. This is intentional at therapeutic doses, not a sign something is wrong.
  • Nausea: Experienced by some patients, particularly without fasting beforehand. Anti-nausea medication can be administered if needed.
  • Elevated blood pressure and heart rate: A known cardiovascular effect that is monitored continuously throughout every infusion.
  • Dizziness or light-headedness: Typically resolves quickly after the infusion ends.
  • Headache or fatigue: Some patients experience these in the hours following treatment.

Serious adverse events at therapeutic doses are rare. Respiratory depression (the primary risk with many anesthetics) does not occur at sub-anesthetic doses.

Who Should Not Receive Ketamine Therapy

Proper screening is what separates safe clinical use from unsafe use. The following contraindications are consistent with the American Psychiatric Association consensus statement (Sanacora et al., 2017). Ketamine is contraindicated in patients with:

  • Uncontrolled hypertension or active cardiovascular disease: The transient blood pressure elevation during infusion poses real risk in this population.
  • A personal or family history of psychosis or schizophrenia: Ketamine can trigger or worsen psychotic symptoms in susceptible individuals.
  • Untreated hyperthyroidism: Can compound cardiovascular effects.
  • Active mania or hypomania (in bipolar patients): Risk of precipitating or worsening a manic episode.
  • Current pregnancy

Patients with substance use history require individual assessment, not automatic exclusion, but careful evaluation.

What “Safe” Requires: Clinical Supervision

Ketamine’s safety in therapeutic use is not inherent to the drug alone; it is inseparable from the clinical context in which it’s delivered. This means:

  • Provider-administered IV infusion: Not nasal spray self-administration, not unmonitored settings.
  • Continuous vital sign monitoring: Blood pressure, heart rate, and oxygen saturation throughout every session.
  • Medical screening beforehand: Thorough history, contraindication review, and medication reconciliation before treatment begins.
  • A clinical team member present at all times: You should never be left alone during an infusion.

At Mosaic Infusions & Wellness, every infusion is conducted in a private room with continuous monitoring by a licensed clinical provider. Your first session includes a dedicated provider visit, built into the $450 rate, to assess your response and establish your protocol.

The Bottom Line

IV ketamine therapy, delivered under proper clinical supervision at sub-anesthetic doses, has a strong safety record supported by decades of research. It is not without risks (no medical treatment is), but those risks are manageable when the appropriate screening, dosing, and monitoring protocols are in place.

The more meaningful question for most patients is not “is ketamine safe?” but “is ketamine right for me?” That’s a question worth exploring with a clinical team who knows your full history.

Interested in whether ketamine therapy might be appropriate for your situation? Schedule a free consultation with the Mosaic team, no obligation, no pressure.